Fascinatingly, the Survodutide studies that I mentioned previously, they measured the number of patients in the placebo group that ultimately were taking another GLP-1 on their own accord and that actually led, that was 20% of that placebo group by the end of the trial actually were taking a GLP-1
In the meantime, the GLP-1 discontinuation wave from Semaglutide and Tirzepatide alone is already creating significant downstream demand, for metabolic support products, muscle preservation, and micronutrient replenishment
Thats the main reason the GLOW peptide blend is primarily associated with aesthetic medicine, while KLOW is mentioned more frequently in the context of healing and post-trauma recovery, often in the sports field
Advanced Practice Registered Nurses (APRNs), which include Nurse Practitioners (NPs) and Clinical Nurse Specialists (CNSs), may have the authority to prescribe semaglutide
Inulin consumption not only promoted weight loss but was also associated with greater loss of triglyceride in the liver (IHCL) and soleus muscle (IMCL-S), even after controlling for differences in weight lost